Dow Up0.36% Nasdaq Up0.12%

Regeneron Pharmaceuticals, Inc. (REGN)

-NasdaqGS
341.51 3.77(1.09%) Aug 21, 4:00PM EDT
Income StatementGet Income Statement for:
View: Annual Data | Quarterly DataAll numbers in thousands
Period EndingJun 30, 2014Mar 31, 2014Dec 31, 2013Sep 30, 2013
Total Revenue 665,700   625,740   610,412   597,027  
Cost of Revenue46,379  43,572  48,114  38,573  
Gross Profit 619,321   582,168   562,298   558,454  
Operating Expenses
Research Development294,501  287,379  268,140  224,045  
Selling General and Administrative102,414  108,850  82,085  97,607  
Non Recurring -   -   -   -  
Others -   -   -   -  
Total Operating Expenses -   -   -   -  
Operating Income or Loss 222,406   185,939   212,073   236,802  
Income from Continuing Operations
Total Other Income/Expenses Net(9,110)937  (2,259)618  
Earnings Before Interest And Taxes213,296  186,876  209,814  237,420  
Interest Expense10,177  11,613  11,661  11,736  
Income Before Tax203,119  175,263  198,153  225,684  
Income Tax Expense110,384  109,820  101,347  84,378  
Minority Interest -   -   -   -  
Net Income From Continuing Ops81,948  65,443  96,806  141,306  
Non-recurring Events
Discontinued Operations -   -   -   -  
Extraordinary Items -   -   -   -  
Effect Of Accounting Changes -   -   -   -  
Other Items -   -   -   -  
Net Income 92,735   65,443   96,806   141,306  
Preferred Stock And Other Adjustments -   -   -   -  
Net Income Applicable To Common Shares 92,735   65,443   96,806   141,306  

Sign Up for a Free Trial to EDGAR Online Premium!
Get the critical business and financial information you need for more than 15,000 U.S. public companies.
Sign Up Now - Learn More

Currency in USD.